C12Y 205/01006
Methionine adenosyltransferase , i.e. adenosylmethionine synthetase
Official title: Methionine adenosyltransferase (2.5.1.6), i.e. adenosylmethionine synthetase
C12Y205/01006 (Methionine adenosyltransferase , i.e. adenosylmethionine synthetase) appears on 21 US grants and 33 published applications in this corpus.
Search patents in C12Y- Granted patents
- 21
- Published applications
- 33
- Assignees
- 22
- Inventors
- 89
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 2 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 1 |
| 2016 | 0 | 4 |
| 2017 | 3 | 3 |
| 2018 | 1 | 3 |
| 2019 | 3 | 2 |
| 2020 | 0 | 2 |
| 2021 | 3 | 0 |
| 2022 | 0 | 3 |
| 2023 | 1 | 2 |
| 2024 | 1 | 4 |
| 2025 | 1 | 1 |
| 2026 | 4 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Genetically engineered bacterium using glucose as substrate for de novo synthesis of vanillin and application thereof4 Aug 2026US 12,698,515 B2Beijing University of Chemical Technology
- Target to treat a metabolic disease in an individual27 Jan 2026US 12,534,727 B2Universidad Del Pais Vasco/Euskal Herriko Unibertsitatea
- Modified host cells for high efficiency production of vanillin6 Jan 2026US 12,516,357 B1Amyris, Inc.
- Microbial cells for spermidine production7 Oct 2025US 12,435,348 B2Chrysea Limited
- Method for producing methyl compound7 May 2026US 2026/0125722 A1Mitsubishi Chemical Corporation
- Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine6 Nov 2025US 2025/0340852 A1Erydel S.P.A.
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism12 Dec 2024US 2024/0409976 A1Les Laboratoires Servier
- Escherichia coli having 3-hydroxypropionate production ability, with 3-hydroxypropionate production gene inserted into same, and use thereof31 Oct 2024US 2024/0360405 A1LG Chem.Ltd.
- Genetically engineered bacterium using glucose as substrate for de novo synthesis of vanillin and application thereof26 Sep 2024US 2024/0318209 A1Beijing University of Chemical Technology
Most cited
By later US patents
- Methods and compositions for preventing norleucine misincorporation into proteins8US 9,850,514 B2Genentech, Inc. · 2017
- Methods for reducing norleucine misincorporation into proteins using a microorganism comprising a mutant metA allele6US 10,421,984 B2Genentech, Inc. · 2019
- Compositions for preventing norleucine misincorporation into proteins5US 10,179,925 B2Genentech, Inc. · 2019
- Secretagogues derived from oxalobacter formigenes4US 10,125,176 B2Oxthera Intellectual Property AB · 2018
- S-adenosylmethionine synthetase expression elements identified from Arabidopsis thaliana2US 8,809,628 B2Monsanto Technology LLC · 2014